Patent ID: 8557828
Filing Date: 2013-10-15
Classification: A61P,C07D

Abstract:
1. A method for treating a disorder selected from the group consisting of type 2 diabetes, obesity, elevated plasma triglycerides, metabolic syndrome, non-alcoholic steatohepatitis, and non-alcoholic fatty liver disease, said method comprising the step of administering to a subject in need thereof a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein R R R m is 1, 2, 3 or 4; R R optionally, R R R R R wherein each of the cycloalkyl, aryl, heteroaryl, heterocycle, cycloalkyl moiety of the cycloalkylalkyl, aryl moiety of the arylalkyl, heteroaryl moiety of the heteroarylalkyl, and heterocycle moiety of the heterocyclealkyl, as represented by R R R R R p, q, and r, at each occurrence, are each independently 1, 2, 3, or 4; R R R R R G